Postoperative Radiotherapy and Radiotherapy Combined with CCNU Chemotherapy for Treatment of Brain Gliomas

Overview

Journal J Neurooncol

Publisher Springer

Date 1988 Nov 1

PMID 3066856

Citations 4

Authors

T Trojanowski

J Peszynski

K TUROWSKI

S Kaminski

I Goscinski

M Reinfus

T Krzyszkowski

M Pyrich

A Bielawski

C Leszczyk

Affiliations

Soon will be listed here.

Abstract

A prospective, randomized trial evaluates the effects of two postoperative treatment regimens on survival in 198 adult patients with supratentorial gliomas. All patients were irradiated with 6,000 rads after possibly radical removal of tumors. CCNU administration in the doses of 100 mg/sq m of body surface every 6-8 weeks following surgery proved to have no significant effect on the survival of patients. The median survival time in patients receiving radiation therapy alone was 61 +/- 7 weeks, while in those receiving additional chemotherapy was 56 +/- 4 weeks. Tumor histological malignancy and patients age were found to be the only important prognostic factors, irrespective of the treatment modality.

Citing Articles

Endu combined with concurrent chemotherapy and radiotherapy for stage IIB-IVA cervical squamous cell carcinoma patients.

Zhao F, Su Q, Zhang W, Yang W, Zhao L, Gao L World J Clin Cases. 2021; 9(27):8061-8070.

PMID: 34621863 PMC: 8462205. DOI: 10.12998/wjcc.v9.i27.8061.

Chemotherapy for high-grade glioma.

Cochrane Database Syst Rev. 2003; (4):CD003913.

PMID: 12519620 PMC: 10625440. DOI: 10.1002/14651858.CD003913.

Chemotherapy for malignant gliomas of the brain: a review of ten-years experience.

Paoletti P, Butti G, Knerich R, Gaetani P, Assietti R Acta Neurochir (Wien). 1990; 103(1-2):35-46.

PMID: 2360465 DOI: 10.1007/BF01420190.

Quality of life self-reports from 200 brain tumor patients: comparisons with Karnofsky performance scores.

MACKWORTH N, Fobair P, PRADOS M J Neurooncol. 1992; 14(3):243-53.

PMID: 1460487 DOI: 10.1007/BF00172600.

References

Hansen H, Muggia F . Treatment of malignant brain tumors with nitrosoureas. Cancer Chemother Rep. 1971; 55(2):99-100. View

Walker M, Green S, Byar D, ALEXANDER Jr E, Batzdorf U, Brooks W . Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. N Engl J Med. 1980; 303(23):1323-9. DOI: 10.1056/NEJM198012043032303. View

Coldman A, Elwood J . Examining survival data. Can Med Assoc J. 1979; 121(8):1065-8, 1071. PMC: 1705014. View

GREENBERG H, ENSMINGER W, Chandler W, Layton P, Junck L, Knake J . Intra-arterial BCNU chemotherapy for treatment of malignant gliomas of the central nervous system. J Neurosurg. 1984; 61(3):423-9. DOI: 10.3171/jns.1984.61.3.0423. View

. Evaluation of CCNU, VM-26 plus CCNU, and procarbazine in supratentorial brain gliomas. Final evaluation of a randomized study. European Organization for Research on Treatment of Cancer (EORTC) Brain Tumor Group. J Neurosurg. 1981; 55(1):27-31. DOI: 10.3171/jns.1981.55.1.0027. View

Reagan T, Bisel H, CHILDS Jr D, LAYTON D, Rhoton Jr A, Taylor W . Controlled study of CCNU and radiation therapy in malignant astrocytoma. J Neurosurg. 1976; 44(2):186-90. DOI: 10.3171/jns.1976.44.2.0186. View

Peto R, Pike M, Armitage P, Breslow N, Cox D, Howard S . Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. Br J Cancer. 1977; 35(1):1-39. PMC: 2025310. DOI: 10.1038/bjc.1977.1. View

. Effect of CCNU on survival rate of objective remission and duration of free interval in patients with malignant brain glioma--final evaluation. E.O.R.T.C. Brain Tumor Group. Eur J Cancer (1965). 1978; 14(8):851-6. DOI: 10.1016/0014-2964(78)90100-7. View

Rosenblum M, Reynolds Jr A, Smith K, Rumack B, Walker M . Chloroethyl-cyclohexyl-nitrosourea (CCNU) in the treatment of malignant brain tumors. J Neurosurg. 1973; 39(3):306-14. DOI: 10.3171/jns.1973.39.3.0306. View

10.

Walker M, ALEXANDER Jr E, HUNT W, MacCARTY C, MAHALEY Jr M, Mealey Jr J . Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial. J Neurosurg. 1978; 49(3):333-43. DOI: 10.3171/jns.1978.49.3.0333. View

11.

Levin V, Crafts D, Norman D, Hoffer P, Spire J, Wilson C . Criteria for evaluating patients undergoing chemotherapy for malignant brain tumors. J Neurosurg. 1977; 47(3):329-35. DOI: 10.3171/jns.1977.47.3.0329. View

12.

Chang C, Horton J, Schoenfeld D, Salazer O, Perez-Tamayo R, Kramer S . Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. A joint Radiation Therapy Oncology Group and Eastern Cooperative Oncology Group study. Cancer. 1983; 52(6):997-1007. DOI: 10.1002/1097-0142(19830915)52:6<997::aid-cncr2820520612>3.0.co;2-2. View

13.

Laws Jr E, Taylor W, Clifton M, Okazaki H . Neurosurgical management of low-grade astrocytoma of the cerebral hemispheres. J Neurosurg. 1984; 61(4):665-73. DOI: 10.3171/jns.1984.61.4.0665. View

14.

. Effect of CCNU on survival, rate of objective remission and duration of free interval in patients with malignant brain glioma--first evaluation. Eur J Cancer (1965). 1976; 12(1):41-5. DOI: 10.1016/0014-2964(76)90122-5. View

15.

Seiler R, Greiner R, Zimmerman A, MARKWALDER H . Radiotherapy combined with procarbazine, bleomycin, and CCNU in the treatment of high-grade supratentorial astrocytomas. J Neurosurg. 1978; 48(6):861-5. DOI: 10.3171/jns.1978.48.6.0861. View

16.

Levin V, Wilson C, Davis R, Wara W, Pischer T, Irwin L . A phase III comparison of BCNU, hydroxyurea, and radiation therapy to BCNU and radiation therapy for treatment of primary malignant gliomas. J Neurosurg. 1979; 51(4):526-32. DOI: 10.3171/jns.1979.51.4.0526. View

17.

Edwards M, Levin V, Wilson C . Brain tumor chemotherapy: an evaluation of agents in current use for phase II and III trials. Cancer Treat Rep. 1980; 64(12):1179-205. View

18.

Wilson C, Gutin P, Boldrey E, Drafts D, Levin V, Enot K . Single-agent chemotherapy of brain tumors. A five-year review. Arch Neurol. 1976; 33(11):739-44. DOI: 10.1001/archneur.1976.00500110007002. View

19.

Wara W . Radiation therapy for brain tumors. Cancer. 1985; 55(9 Suppl):2291-5. DOI: 10.1002/1097-0142(19850501)55:9+<2291::aid-cncr2820551437>3.0.co;2-c. View

20.

Afra D, Kocsis B, Dobay J, Eckhardt S . Combined radiotherapy and chemotherapy with dibromodulcitol and CCNU in the postoperative treatment of malignant gliomas. J Neurosurg. 1983; 59(1):106-10. DOI: 10.3171/jns.1983.59.1.0106. View